DePuy Synthes received FDA 510(k) clearance for its minimally invasive spine platform, Teligen, the devicemaker said Oct. 20.
Teligen was cleared for minimally invasive transforaminal lumbar interbody fusion, according to a news release. The system delivers technologies including camera controls, a VueLIF-T procedure kit, a Teligen clear discectomy device and patient-based disposable ports.
Teligen integrates with the Unleash family of implants, which are designed to streamline the main stages of MIS-TLIF.
The system is expected to be available later in 2022. DePuy Synthes is the orthopedics company for Johnson & Johnson.